Shares of Rite Aid Corporation RAD surged in Friday’s pre-market following the release of December sales results.
Total drugstore sales for the four-week period increased 4.9 percent to $2.212 billion compared to $2.109 billion for the same period last year.
Prescription sales accounted for 64.8 percent of drugstore sales, and third party prescription sales represented 97.6 percent of pharmacy sales.
Same-store sales increased 5.3 percent over the prior-year period. December front-end same store sales increased 1.7 percent.
Pharmacy same-store sales, which included an approximate 123 basis points negative impact from new generic introductions, increased 7.3 percent. Prescription count at comparable stores increased 5.1 percent over the prior-year period.
The December period covered the four weeks ended December 27, 2014.
Rite Aid traded at $7.62 percent in the pre-market, up 1.33 percent.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.